These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 18794908)

  • 21. Assessment of drug metabolism enzyme and transporter pharmacogenetics in drug discovery and early development: perspectives of the I-PWG.
    Brian W; Tremaine LM; Arefayene M; de Kanter R; Evers R; Guo Y; Kalabus J; Lin W; Loi CM; Xiao G
    Pharmacogenomics; 2016 Apr; 17(6):615-31. PubMed ID: 27045656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacogenetic/regulatory aspects seen from the viewpoint of the industry].
    Hansen L; Andersen D
    Ugeskr Laeger; 2005 May; 167(20):2160-4. PubMed ID: 15987073
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacogenetics: from discovery to patient care.
    Shin J; Kayser SR; Langaee TY
    Am J Health Syst Pharm; 2009 Apr; 66(7):625-37. PubMed ID: 19299369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Why, when, and how should pharmacogenetics be applied in clinical studies?: current and future approaches to study designs.
    Stingl Kirchheiner JC; Brockmöller J
    Clin Pharmacol Ther; 2011 Feb; 89(2):198-209. PubMed ID: 21209614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacogenomics in psychiatry: clinical issues to be considered.
    Licinio J; Wong ML
    Mol Psychiatry; 2005 Jul; 10(7):615. PubMed ID: 15976808
    [No Abstract]   [Full Text] [Related]  

  • 26. The ethical implications of stratifying by race in pharmacogenomics.
    Lee SS
    Clin Pharmacol Ther; 2007 Jan; 81(1):122-5. PubMed ID: 17186010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Applications of microarrays and biochips in pharmacogenomics.
    Hardiman G
    Methods Mol Biol; 2008; 448():21-30. PubMed ID: 18370228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacogenomics and therapeutic strategies for dementia.
    Cacabelos R
    Expert Rev Mol Diagn; 2009 Sep; 9(6):567-611. PubMed ID: 19732004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retrospective validation of genomic biomarkers-- what are the questions, challenges and strategies for developing useful relationships to clinical outcomes-- workshop summary.
    Wang SJ; Cohen N; Katz DA; Ruano G; Shaw PM; Spear B
    Pharmacogenomics J; 2006; 6(2):82-8. PubMed ID: 16402078
    [No Abstract]   [Full Text] [Related]  

  • 30. Preparing for the revolution--pharmacogenomics and the clinical lab.
    Mehr IJ
    Pharmacogenomics; 2000 Feb; 1(1):1-4. PubMed ID: 11258591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacogenomics in Asia.
    Tamaoki M; Gushima H; Tsutani K
    Pharmacogenomics; 2004 Dec; 5(8):1023-7. PubMed ID: 15584872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beyond genomics.
    Dollery CT
    Clin Pharmacol Ther; 2007 Oct; 82(4):366-70. PubMed ID: 17851575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Applying technologies towards safe and effective medicines.
    Roses AD
    Biotechniques; 2005 Oct; 39(4):563-4. PubMed ID: 16235568
    [No Abstract]   [Full Text] [Related]  

  • 34. An industry survey on current practices in the design and analysis of active control studies.
    Chuang-Stein C; Sanders C; Snapinn S
    J Biopharm Stat; 2004 May; 14(2):349-58. PubMed ID: 15206532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Awareness survey of parties involved in pharmacogenomics in Japan.
    Tamaoki M; Gushima H; Tsutani K
    Pharmacogenomics; 2007 Mar; 8(3):275-86. PubMed ID: 17324116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacogenomics: principles and perspectives].
    Mahlknecht U
    Dtsch Med Wochenschr; 2006 Feb; 131(7):310-3. PubMed ID: 16468099
    [No Abstract]   [Full Text] [Related]  

  • 37. The Affymetrix DMET platform and pharmacogenetics in drug development.
    Deeken J
    Curr Opin Mol Ther; 2009 Jun; 11(3):260-8. PubMed ID: 19479659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenomics and diagnostics.
    Persidis A
    Nat Biotechnol; 1998 Aug; 16(8):791-2. PubMed ID: 9702782
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacogenetics--pivotal to the future of the biopharmaceutical industry.
    Foot E; Kleyn D; Palmer Foster E
    Drug Discov Today; 2010 May; 15(9-10):325-7. PubMed ID: 20298799
    [No Abstract]   [Full Text] [Related]  

  • 40. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.